Erratum to: A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis

समान संसाधन

• A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis
  द्वारा: Campa, Molly, और अन्य
  प्रकाशित: (2015)
• IL-17 and IL-23 Inhibitors in Moderate to Severe Plaque Psoriasis as Part of Current Therapeutic Strategies
  द्वारा: Ieva Saulite, और अन्य
  प्रकाशित: (2024-07-01)
• New and emerging biologic therapies for moderate-to-severe plaque psoriasis: mechanistic rationales and recent clinical data for IL-17 and IL-23 inhibitors
  द्वारा: Gaspari, Anthony A, और अन्य
  प्रकाशित: (2015)
• Erratum: Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting
  प्रकाशित: (2021)
• Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis
  द्वारा: Frieder, Jillian, और अन्य
  प्रकाशित: (2017)